{"Exaggerate": "The claim exaggerates the statement made by the FDA in 2015, stating that 70% of chickens sold for food in the U.S. contain cancer-causing arsenic. The expert's verdict clarifies that the FDA did not make such an announcement in 2015.", "Lack enough support": "The claim lacks sufficient support as it does not provide any evidence or sources to back up the statement about the FDA's admission. The expert's verdict provides the necessary information to refute the claim.", "Problematic assumption": "The claim assumes that the FDA admitted in 2015 that 70% of chickens sold for food in the U.S. contain cancer-causing arsenic. However, the expert's verdict clarifies that the claim is based on a misinterpretation of an article published in 2015, which caused widespread concern but did not reflect the FDA's official announcement.", "Contradict fact": "The claim contradicts the fact that the FDA did not announce in 2015 that 70% of chickens contain cancer-causing arsenic, as stated by the expert's verdict.", "Falters at times": "The claim falters by misrepresenting the FDA's announcement and making an inaccurate statement about the prevalence of cancer-causing arsenic in chickens. The expert's verdict corrects these inaccuracies.", "Exist alternative explanation": "The claim does not provide an alternative explanation for the presence of arsenic in chickens. However, the expert's verdict explains that the arsenic was present due to the use of an arsenic-containing feed additive called Roxarsone, which was discontinued by Pfizer in 2011.", "Understate": "There is no evidence of understatement in the claim or the expert's verdict."}